These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31844124)

  • 1. Collision cross sections obtained with ion mobility mass spectrometry as new descriptor to predict blood-brain barrier permeation by drugs.
    Guntner AS; Thalhamer B; Klampfl C; Buchberger W
    Sci Rep; 2019 Dec; 9(1):19182. PubMed ID: 31844124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of topochemical models for the prediction of permeability through the blood-brain barrier.
    Dureja H; Madan AK
    Acta Pharm; 2007 Dec; 57(4):451-67. PubMed ID: 18165189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial least square and hierarchical clustering in ADMET modeling: prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands.
    Nikolic K; Filipic S; Smoliński A; Kaliszan R; Agbaba D
    J Pharm Pharm Sci; 2013; 16(4):622-47. PubMed ID: 24210068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collision cross section (CCS) as a complementary parameter to characterize human and veterinary drugs.
    Tejada-Casado C; Hernández-Mesa M; Monteau F; Lara FJ; Olmo-Iruela MD; García-Campaña AM; Le Bizec B; Dervilly-Pinel G
    Anal Chim Acta; 2018 Dec; 1043():52-63. PubMed ID: 30392669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-Scale Evaluation of Collision Cross Sections to Investigate Blood-Brain Barrier Permeation of Drugs.
    Guntner AS; Bögl T; Mlynek F; Buchberger W
    Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration.
    Heymans M; Sevin E; Gosselet F; Lundquist S; Culot M
    Eur J Pharm Biopharm; 2018 Jun; 127():453-461. PubMed ID: 29602020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ionization-specific QSAR models of blood-brain penetration of drugs.
    Lanevskij K; Japertas P; Didziapetris R; Petrauskas A
    Chem Biodivers; 2009 Nov; 6(11):2050-4. PubMed ID: 19937840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands using PAMPA technique and quantitative-structure permeability relationship analysis.
    Vucicevic J; Nikolic K; Dobričić V; Agbaba D
    Eur J Pharm Sci; 2015 Feb; 68():94-105. PubMed ID: 25542610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico prediction models for blood-brain barrier permeation.
    Ecker GF; Noe CR
    Curr Med Chem; 2004 Jun; 11(12):1617-28. PubMed ID: 15180567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the utility of momentum-space descriptors for predicting blood-brain barrier penetration.
    Al-Fahemi JH; Cooper DL; Allan NL
    J Mol Graph Model; 2007 Oct; 26(3):607-12. PubMed ID: 17300970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Simple Method to Predict Blood-Brain Barrier Permeability of Drug- Like Compounds Using Classification Trees.
    Castillo-Garit JA; Casanola-Martin GM; Le-Thi-Thu H; Pham-The H; Barigye SJ
    Med Chem; 2017; 13(7):664-669. PubMed ID: 28185535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indexes of polar interactions between ionizable drugs and membrane phospholipids measured by IAM-HPLC: their relationships with data of Blood-Brain Barrier passage.
    Grumetto L; Russo G; Barbato F
    Eur J Pharm Sci; 2014 Dec; 65():139-46. PubMed ID: 25262853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative prediction of blood-brain barrier permeability on a large and refined dataset.
    Muehlbacher M; Spitzer GM; Liedl KR; Kornhuber J
    J Comput Aided Mol Des; 2011 Dec; 25(12):1095-106. PubMed ID: 22109848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new descriptor via bio-mimetic chromatography and modeling for the blood brain barrier (Part II).
    Kouskoura MG; Piteni AI; Markopoulou CK
    J Pharm Biomed Anal; 2019 Feb; 164():808-817. PubMed ID: 29884296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysing molecular polar surface descriptors to predict blood-brain barrier permeation.
    Shityakov S; Neuhaus W; Dandekar T; Förster C
    Int J Comput Biol Drug Des; 2013; 6(1-2):146-56. PubMed ID: 23428480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topochemical models for the prediction of permeability through blood-brain barrier.
    Dureja H; Madan AK
    Int J Pharm; 2006 Oct; 323(1-2):27-33. PubMed ID: 16815653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of drug permeability across blood brain barrier using nanoparticles in meningitis.
    Nair KGS; Ramaiyan V; Sukumaran SK
    Inflammopharmacology; 2018 Jun; 26(3):675-684. PubMed ID: 29582240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ion Mobility-Mass Spectrometry to Evaluate the Effects of Protein Modification or Small Molecule Binding on Protein Dynamics.
    Tomlinson LJ; Eyers CE
    Methods Mol Biol; 2020; 2084():179-190. PubMed ID: 31729661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A BOILED-Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules.
    Daina A; Zoete V
    ChemMedChem; 2016 Jun; 11(11):1117-21. PubMed ID: 27218427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-brain barrier permeability considerations for CNS-targeted compound library design.
    Hitchcock SA
    Curr Opin Chem Biol; 2008 Jun; 12(3):318-23. PubMed ID: 18435937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.